Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

41.10
Delayed Data
As of 4:01pm ET
 +0.09 / +0.22%
Today’s Change
37.20
Today|||52-Week Range
44.54
+6.73%
Year-to-Date

Today’s Trading

Previous close41.01
Today’s open40.99
Day’s range40.98 - 41.24
Volume3,248,835
Average volume (3 months)2,948,388
Market cap$100.9B
Dividend yield4.93%
Data as of 4:01pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+14.87%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+2.85%
P/E ratio52.2
Price/Sales2.52
Price/Book71.86

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.97+1.52%
NVONovo Nordisk+0.55+1.10%
CELGCelgene-1.21-0.88%
ABTAbbott Laboratories+0.23+0.41%
Data as of 4:02pm ET, 10/19/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts